Syndax Announces Participation at Two Upcoming Investor Conferences

Rhea-AI Summary

Syndax Pharmaceuticals (SNDX) to participate in investor conferences to discuss cancer therapies. Management team to join fireside chats and panel discussions at TD Cowen's and Barclays Global Healthcare Conferences in March 2024.

WALTHAM, Mass., Feb. 26, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that members of its management team will participate in the following sessions at two upcoming investor conferences:

• A fireside chat at TD Cowen's 44^th Annual Health Care Conference at 9:50 a.m. ET on Monday, March 4, 2024 in Boston, MA
• A corporate panel discussion on leukemia at TD Cowen's 44^th Annual Health Care Conference at 12:50 p.m. ET on Monday, March 4, 2024 in Boston, MA
• A fireside chat at the Barclays Global Healthcare Conference at 8:30 a.m. ET on Tuesday, March 12, 2024 in Miami, FL

A live webcast of these sessions can be accessed from the Investor section of the Company's website at www.syndax.com, where a replay will also be available for a limited time.

About Syndax

Syndax Pharmaceuticals is a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include revumenib, a highly selective inhibitor of the menin–KMT2A binding interaction, and axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. For more information, please visit www.syndax.com or follow the Company on X (formerly Twitter) and LinkedIn.

Syndax Contacts

Sharon Klahre
Syndax Pharmaceuticals, Inc.
sklahre@syndax.com
Tel 781.684.9827

SNDX-G

View original content:https://www.prnewswire.com/news-releases/syndax-announces-participation-at-two-upcoming-investor-conferences-302070276.html

SOURCE Syndax Pharmaceuticals, Inc.

FAQ

When will Syndax Pharmaceuticals participate in investor conferences?

Syndax Pharmaceuticals will participate in investor conferences in March 2024.

What is the purpose of the fireside chat at TD Cowen's 44th Annual Health Care Conference?

The purpose of the fireside chat at TD Cowen's 44th Annual Health Care Conference is to discuss cancer therapies.

Where can the live webcast of the sessions be accessed?

The live webcast of the sessions can be accessed from the Investor section of Syndax Pharmaceuticals' website at www.syndax.com.